Get started
AlvotechAlvotechAlvotech

Alvotech

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ALVO chart


Full chart

ALVO upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.88 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.85 USD
Net income (FY)
‪−231.86 M‬ USD
Revenue (FY)
‪489.68 M‬ USD
Shares float
‪109.14 M‬
Beta (1Y)
0.61

Employees


Employees (FY)
‪1.03 K‬
Change (1Y)
+6 +0.58%
Revenue / Employee (1Y)
‪474.50 K‬ USD
Net income / Employee (1Y)
‪−224.67 K‬ USD

About Alvotech


Sector
Health Technology
Industry
Biotechnology
CEO
Vilhelm Róbert Wessman
Website
alvotech.com
Headquarters
Luxembourg
Founded
2021
ISIN
LU2458332611
FIGI
BBG014MBMZY2
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ALVO news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as ALVO.

Frequently Asked Questions


The current price of ALVO is 9.67 USD — it has decreased by −7.82% in the past 24 hours. Watch Alvotech stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Alvotech stocks are traded under the ticker ALVO.
ALVO stock has fallen by −17.32% compared to the previous week, the month change is a −19.48% fall, over the last year Alvotech has showed a −23.07% decrease.
We've gathered analysts' opinions on Alvotech future price: according to them, ALVO price has a max estimate of 28.00 USD and a min estimate of 14.00 USD. Watch ALVO chart and read a more detailed Alvotech stock forecast: see what analysts think of Alvotech and suggest that you do with its stocks.
ALVO reached its all-time high on Feb 26, 2024 with the price of 18.00 USD, and its all-time low was 5.20 USD and was reached on Jul 15, 2022. View more price dynamics on ALVO chart.
See other stocks reaching their highest and lowest prices.
ALVO stock is 4.87% volatile and has beta coefficient of 0.61. Track Alvotech stock price on the chart and check out the list of the most volatile stocks — is Alvotech there?
Today Alvotech has the market capitalization of ‪2.88 B‬, it has increased by 4.63% over the last week.
Yes, you can track Alvotech financials in yearly and quarterly reports right on TradingView.
Alvotech is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
ALVO earnings for the last quarter are −0.18 USD per share, whereas the estimation was −0.03 USD resulting in a −559.34% surprise. The estimated earnings for the next quarter are 0.03 USD per share. See more details about Alvotech earnings.
Alvotech revenue for the last quarter amounts to ‪153.40 M‬ USD, despite the estimated figure of ‪97.99 M‬ USD. In the next quarter, revenue is expected to reach ‪103.68 M‬ USD.
ALVO net income for the last quarter is ‪−66.97 M‬ USD, while the quarter before that showed ‪−11.39 M‬ USD of net income which accounts for −487.79% change. Track more Alvotech financial stats to get the full picture.
No, ALVO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 31, 2025, the company has ‪1.03 K‬ employees. See our rating of the largest employees — is Alvotech on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Alvotech EBITDA is ‪74.23 M‬ USD, and current EBITDA margin is 20.15%. See more stats in Alvotech financial statements.
Like other stocks, ALVO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Alvotech stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Alvotech technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Alvotech stock shows the strong sell signal. See more of Alvotech technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.